Gene: PRKDC
Official Full Name: protein kinase, DNA-activated, catalytic subunitprovided by HGNC
Gene Summary: This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00300 | PRKDC Knockout cell line(HEK293) | Human | PRKDC | 1:3~1:6 | Negative | Online Inquiry |
KO02062 | PRKDC Knockout cell line (HeLa) | Human | PRKDC | 1:3~1:6 | Negative | Online Inquiry |
KO02063 | PRKDC Knockout cell line (HCT 116) | Human | PRKDC | 1:2~1:4 | Negative | Online Inquiry |
KO02064 | PRKDC Knockout cell line (A549) | Human | PRKDC | 1:3~1:4 | Negative | Online Inquiry |
PRKDC Gene Knockout Cell Lines represent a groundbreaking advancement in genomic and cellular research, focusing on the disruption of the PRKDC gene, which encodes the DNA-dependent protein kinase. The primary function of this kinase is to repair DNA double-strand breaks, a crucial mechanism for maintaining genomic stability. By knocking out this gene, researchers can effectively simulate conditions associated with genomic instability, allowing for a deeper understanding of cancer biology, DNA repair pathways, and cellular responses to genotoxic stress.
The unique mechanism of action in these cell lines involves the complete inactivation of the PRKDC gene, leading to impaired DNA repair and subsequent accumulation of DNA damage. This impairment can be leveraged in various experimental setups, from studying the effects of ionizing radiation to examining the therapeutic efficacy of chemotherapeutic agents. The scientific importance of these cell lines lies in their ability to provide a relevant model for exploring cancer-induced alterations in DNA repair processes, making them crucial in drug discovery and the development of targeted therapies.
Compared to existing alternatives, the PRKDC Gene Knockout Cell Lines offer a more precise and reliable model for investigating the role of the PRKDC gene in cellular responses to DNA damage. The robust nature of these cells enhances reproducibility in experimental designs and allows researchers to achieve more consistent results. Furthermore, these knockout lines facilitate the study of PRKDC’s interaction with other pathways and proteins, paving the way for discoveries that can lead to innovative therapies.
The value of PRKDC Gene Knockout Cell Lines to researchers, clinicians, and pharmaceutical companies cannot be overstated. They represent not just an innovative tool for fundamental research but also a potential pathway to novel therapeutic strategies for cancers characterized by deficiencies in DNA repair mechanisms. As a company specializing in cutting-edge biological products, our expertise ensures that you receive high-quality, validated gene knockout cell lines that meet the rigorous standards of modern research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.